REFERENCES
- Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990; 161: 626–633.
- Lamouliatte H. Treatment des gastrites croniques asso-ciees a Campylobacter pylon. Gastroenterol Clin Biol 1989; 13: 101B-106B.
- Blaser MJ. Hypothesis on the pathogenesis and natural history of Helicobacter pylon-induced inflammation. Gastroenterology 1992; 102: 720–727.
- Forman D. Helicobacter pylori: infection and gastric car-cinogenesis. Eur J Gasroenterol Hepatol 1992; 452: 31–36.
- Morris A, Nicholson G. Campylobacter pylon; human ingestion studies. In: Rathbone BJ, Heatley RV, eds. Campylobacter pylori and gastroduodenal disease. Oxford: Blackwells Scientific Publishers, 1989: 185–189.
- Newell DG, Bell GD, Weil J et al. The effect of treat-ment on circulating anti-Helicobacter pylon antibodies—a two year follow-up study. In: Malfertheiner P., Ditschuneit H. eds. Helicobacter pylori, gastritis and peptic ulcer. Berlin: Springer Verlag, 1990: 172-175.
- Glupczywski Y, Burette A, Nyst JF et al. Campylobacter pylori-associated gastritis—attempts to eradicate the bacteria by various antibiotic and anti-ulcer regimens. Act Gastroenterol Belg 1988; 51: 329–337.
- Debbia EA, Pesce A, Schito GC. Helicobacter pylori: approcci terapeutici. Microbiol Med 1992; 7, Suppl.
- Perkins SE, Yan LL, Shen Z, Hayward A, Murphy JC, Fox JC. Use of PCR and culture to detect Helicobacter pylori in naturally infected cats following triple antimicrobial thera-py. Antimicrob Agents Chemother 1996; 40: 1486–1490.
- Bayerdooreer E, Kasper G, Sommer A, Ottejan R. Is Campylobacter pylori a pathogenic factor in duodenal ulcer? In: Acta the IV international workshop on Campylobacter pyloridis, Goteborg, 1987: June 16-18.
- Bell GD, Powell KU, Burridge SM, et al. Helicobacter pylon eradication: efficacy and side effect profile of a combi-nation of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Ore J Med 1993; 86: 743–750.
- Borody TJ, George LL, Brandl S, et al. Helicobacter pylon eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy. Scand J Gastroenterol 1992; 27: 281–284.
- Graham DY, Openkun AR, Klein PD. Clarithromycin for the eradication of Helicobacter pylon. J Clin Gastroenterol 1993; 16: 292–294.
- Kimura K, Ido K, Saifuku K, et al. A 1-h topical thera-py for treatment of Helicobacter pylori infection. Am J Gastroenterol 1995; 90: 60–63.
- Logan RP, Gummet PA, Schaufelberger HD, et al. Eradication of Helicobacter pylon with darithromycin and omeprazole. Gut 1994; 35: 323–326.
- Noach LA, Bertola MA, Schwartz MP, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: an evaluation of various therapeutic trials. Eur J Gastroenterol Hepatol 1994; 6: 585–591.
- Sung JJY, Chung SCS, Ling TKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139–142.
- Xia H, Daw MA, Sant S, Beattie S, Keane CT, O'Morian CA. Clinical efficacy of triple therapy in Helicobacter pylon-associated duodenal ulcer. Eur J Gastroenterol Hepatol 1993; 5: 141–144.
- Lamouliatte H. Coment et pourquoi eradiquer Helicobacter pylon? La lettre de L'Infectiologue. 1993; VIII, n.5.
- Becx MCJM, Jansen AJHM, Clasener HAL, Dekonung RW. Metronidazole resistant Helicobacter pylon (Letter). Lancet 1990; 1: 539–540.
- Bell GD, Weil J, Powell K, et al. Helicobacter pylori treated with combinations of tripotassium dicitrate and metronidazole: efficacy of different treatment regimens and some observations on the emergence of metronidazole resis-tance. Eur J Gastroenterol Hepatol 1991; 3: 819–822.
- Cerdebrant G, Kahalmeter G, Ljiungh A. Proposed mechanism for metronidazole resistance in Helicobacter pylon. J Antimicrob Chemother 1992; 29: 115–120.
- Edwards DI. Nitroimidazole drugs—action and resis-tance mechanism. I. Mechanism of action. J Antimicrob Chemother 1993; 31: 9–20.
- Edwards DI. Nitroimidazole drugs—action and resis-tance mechanism. II. Mechanism of action. J Antimicrob Chemother 1993; 31: 201–210.
- Haas CE, Nix DE, Schentag JJ. In vitro selection of resistant Helicobacter pylori. Antimicrob Agents Chemother 1990; 34: 1637–1641.
- Thijs JC, Vanzwet AA, Oey HB. Efficacy and side effect of a triple drug regimen for eradication of Helicobacter pylori. Scand J Gastroenterol 1993; 28: 634–938.
- Vaira D, Holton J, Cairns SR et al. Titoli anticorpali nei confronti del Campylobacter pylon dopo trattamento per gas-trite. Br Med J (Ed. italiana) 1988; 9: 374–375.